EXAI vs. SDGR

Last updated Jun 4, 2026

EXAI (Exscientia Ltd ADR) and SDGR (Schrodinger, Inc.) are both stocks. Both are in the Healthcare sector — EXAI in Biotechnology, SDGR in Health Information Services. At a 0.38 correlation, their price movements are largely independent.

Performance

EXAI vs. SDGR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Exscientia Ltd ADR (EXAI) and Schrodinger, Inc. (SDGR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

EXAI

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

SDGR

• 1D: -0.07%
• 1M: 15.74%
• YTD: -16.50%
• 6M: -15.84%
• 1Y: -34.80%
• 3Y*: -25.18%
• 5Y*: -26.96%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

EXAI vs. SDGR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
EXAI Exscientia Ltd ADR	0.00%	0.00%	-24.49%	20.26%	-73.03%	-27.08%
SDGR Schrodinger, Inc.	-16.50%	-7.31%	-46.12%	91.55%	-46.34%	-35.49%

Correlation

The correlation between EXAI and SDGR is 0.38, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (3Y) Calculated over the trailing 3-year period	0.29
Correlation (All Time) Calculated using the full available price history since Oct 4, 2021	0.38

Fundamentals

Total Revenue (TTM) EXAI : $17.07M SDGR : $254.91M
Gross Profit (TTM) EXAI : -$11.56M SDGR : $141.04M
EBITDA (TTM) EXAI : -$135.58M SDGR : -$85.22M

Return for Risk

EXAI vs. SDGR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SDGR

SDGR Risk / Return Rank: 17
SDGR Sharpe Ratio Rank: 13
SDGR Sortino Ratio Rank: 15
SDGR Omega Ratio Rank: 16
SDGR Calmar Ratio Rank: 19
SDGR Martin Ratio Rank: 23

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EXAI vs. SDGR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Exscientia Ltd ADR (EXAI) and Schrodinger, Inc. (SDGR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	EXAI	SDGR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.66	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.43	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.14	—

Drawdowns

Drawdown Indicators

	EXAI	SDGR	Difference
Max Drawdown Largest peak-to-trough decline	—	-90.21%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-58.52%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-80.01%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-85.95%	—
Current Drawdown Current decline from peak	—	-86.80%	—
Average Drawdown Average peak-to-trough decline	—	-64.02%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	38.46%	—

Volatility

Volatility by Period

	EXAI	SDGR	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	15.91%	—
Volatility (6M) Calculated over the trailing 6-month period	—	37.14%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	52.90%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	63.18%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	69.86%	—

Dividends

EXAI vs. SDGR - Dividend Comparison

Neither EXAI nor SDGR has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both EXAI and SDGR in my portfolio?

EXAI and SDGR have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.